STOCK TITAN

Rani Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

SAN JOSE, Calif., May 3, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics, a clinical-stage biotherapeutics company, announced that CEO Talat Imran will present at two investment conferences in May. The Bank of America 2022 Healthcare Conference is scheduled for May 10 at 5:20 PM PT, while the H.C. Wainwright Annual Global Life Sciences Conference will take place on May 24 at 10:30 AM PT. Interested participants can access the live webcasts on Rani's Investor Relations page, with replays available for 90 days post-presentation.

Positive
  • None.
Negative
  • None.

SAN JOSE, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the company’s Chief Executive Officer, Talat Imran, will present at two upcoming investor conferences in May:

Bank of America 2022 Healthcare Conference. Mr. Imran will present on Tuesday, May 10 at 5:20 PM Pacific Time / 8:20 PM Eastern Time.

H.C. Wainwright Annual Global Life Sciences Conference. Mr. Imran will present on Thursday, May 24 at 10:30 AM Pacific Time / 1:30 PM Eastern Time.

Interested parties can access the live webcasts for these conferences from the Investor Relations section of the company's website at www.ranitherapeutics.com. The webcast replays will be available after the conclusion of the respective presentations for approximately 90 days.

Rani Therapeutics

Rani Therapeutics is a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics. Rani has developed RaniPill™ capsules, which are a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill™ capsules.  For more information, visit ranitherapeutics.com.

Investor Contact:

investors@ranitherapeutics.com

Media Contact:

media@ranitherapeutics.com

Source: Rani Therapeutics


FAQ

When will Rani Therapeutics present at the Bank of America 2022 Healthcare Conference?

Rani Therapeutics will present at the Bank of America 2022 Healthcare Conference on May 10, 2022, at 5:20 PM Pacific Time.

What time is the H.C. Wainwright Annual Global Life Sciences Conference presentation for Rani Therapeutics?

The H.C. Wainwright Annual Global Life Sciences Conference presentation by Rani Therapeutics is scheduled for May 24, 2022, at 10:30 AM Pacific Time.

How can I access the webcasts for Rani Therapeutics' investor presentations?

The webcasts for Rani Therapeutics' presentations can be accessed from the Investor Relations section of their website at www.ranitherapeutics.com.

What is the focus of Rani Therapeutics as a company?

Rani Therapeutics focuses on advancing technologies for the oral delivery of biologics, including their proprietary RaniPill™ capsules.

What technology does Rani Therapeutics use for oral drug delivery?

Rani Therapeutics utilizes the RaniPill™ capsules, a patented platform designed to replace subcutaneous injections with oral dosing.

Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

RANI Rankings

RANI Latest News

RANI Stock Data

73.75M
32.29M
30.61%
10.14%
8.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAN JOSE